Literature DB >> 54581

Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity.

F Appelbaum, J A Strauchen, R G Graw, D D Savage, K M Kent, V J Ferrans, G P Herzig.   

Abstract

An acute lethal myopericarditis has been observed in four out of fifteen patients receiving high-dose combination chemotherapy which includes cyclophosphamide 45 mg/kg/day for four days. In all cases the myopericarditis occurred 5-9 days after the initiation of chemotherapy, with dyspnoea, tachycardia, orthostatic hypotension, fluid retention, decreased voltage on electrocardiography, and pericardial effusion documented by echocardiogram, and progressed in 2 to 6 days to a fatal low-output state despite vigorous treatment. In three of the four patients, necropsy was permitted and revealed the unique pathological finding of fibrin microthrombi in capillaries, fibrin strands in the interstitium, and fibrin strands within the heart-muscle cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 54581     DOI: 10.1016/s0140-6736(76)90151-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study.

Authors:  W P Peters; A Stuart; M Klotman; C Gilbert; R B Jones; E J Shpall; J Gockerman; R C Bast; J O Moore
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.

Authors:  Chandra K Ala; Allan L Klein; Javid J Moslehi
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

3.  Insight into the role of DL-alpha-lipoic acid against cyclophosphamide induced alterations in calcium sensitivity of cardiac myofilaments.

Authors:  Y Mythili; P T Sudharsan; P Varalakshmi
Journal:  Mol Cell Biochem       Date:  2006-04-20       Impact factor: 3.396

4.  Cardiotoxic effects of anthracyclines.

Authors:  M R Bristow
Journal:  West J Med       Date:  1983-09

Review 5.  Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis.

Authors:  Saamir A Hassan; Nicolas Palaskas; Peter Kim; Cezar Iliescu; Juan Lopez-Mattei; Elie Mouhayar; Rohit Mougdil; Kara Thompson; Jose Banchs; Syed Wamique Yusuf
Journal:  Curr Atheroscler Rep       Date:  2018-02-08       Impact factor: 5.113

6.  The analysis of the parameters of 24-hr ECG Holter monitoring in patients with blood neoplasms undergoing high-dose chemotherapy and stem cell transplantation.

Authors:  Małgorzata Poręba; Paweł Gać; Lidia Usnarska-Zubkiewicz; Witold Pilecki; Kazimierz Kuliczkowski; Grzegorz Mazur; Małgorzata Sobieszczańska; Rafał Poręba
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-01-24       Impact factor: 1.468

7.  Cardiac damage in autologous bone marrow transplant patients: an autopsy study. Cardiotoxic pretreatment as a major risk factor.

Authors:  A von Herbay; B Dörken; G Mall; M Körbling
Journal:  Klin Wochenschr       Date:  1988-12-01

Review 8.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

Review 9.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

Review 10.  Intensive chemotherapy for solid tumours--current clinical applications.

Authors:  S B Kaye
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.